Submitted by Anonymous (not verified) on 9 April 2026 - 16:03
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Sorafenib Accord, sorafenib, Date of authorisation: 09/11/2022, Revision: 5, Status: Authorised